Senior insider sale
CEO & President at DYNE THERAPEUTICS, INC. — senior position signals high conviction
$95.9K
5.39K shares
What this filing means
COX JOHN plans to sell 5.39K shares of DYNE THERAPEUTICS, INC. valued at approximately $95.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/5/2026ACC: 0001972481-26-000086
DirectorOfficer· CEO & President
Since Mar 2026
5.39K
Shares to sell
$95.9K
Approx. market value
9.08K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
Equity Compensation
3/4/2026
9.08KTotal acquired9.08K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/4/2026 | Restricted Stock Units Equity Compensation | 9.08K | — |
| Total | 9.08K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
2.66K
Market value
$55.1K
12/5/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
2.73K
Market value
$40.7K
3/5/2026
Total
Units
5.39K
Value
$95.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/5/2025 | 2.66K | $55.1K | — | Completed |
| Planned — Approximate Date | ||||
3/5/2026 | 2.73K | $40.7K | Nasdaq | Planned |
| Total | 5.39K | $95.9K | ||